[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Plasma Fractionation Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

April 2024 | 190 pages | ID: GFEDB5E45335EN
APO Research

US$ 3,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.

According to APO Research, The global Plasma Fractionation market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Plasma Fractionation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Plasma Fractionation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Plasma Fractionation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Plasma Fractionation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Plasma Fractionation, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Plasma Fractionation, also provides the sales of main regions and countries. Of the upcoming market potential for Plasma Fractionation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plasma Fractionation sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Plasma Fractionation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Plasma Fractionation sales, projected growth trends, production technology, application and end-user industry.

Plasma Fractionation segment by Company
  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
Plasma Fractionation segment by Type
  • Albumin
  • Immune Globulin
  • Coagulation Factor
  • Others
Plasma Fractionation segment by Application
  • Immunology
  • Hematology
  • Others
Plasma Fractionation segment by Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Fractionation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plasma Fractionation market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Plasma Fractionation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Plasma Fractionation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Plasma Fractionation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Plasma Fractionation Market Size, 2019 VS 2023 VS 2030
1.3 Global Plasma Fractionation Market Size Estimates and Forecasts (2019-2030)
1.4 Global Plasma Fractionation Sales Estimates and Forecasts (2019-2030)
1.5 Global Plasma Fractionation Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives

2 GLOBAL PLASMA FRACTIONATION MARKET DYNAMICS

2.1 Plasma Fractionation Industry Trends
2.2 Plasma Fractionation Industry Drivers
2.3 Plasma Fractionation Industry Opportunities and Challenges
2.4 Plasma Fractionation Industry Restraints

3 PLASMA FRACTIONATION MARKET BY MANUFACTURERS

3.1 Global Plasma Fractionation Revenue by Manufacturers (2019-2024)
3.2 Global Plasma Fractionation Sales by Manufacturers (2019-2024)
3.3 Global Plasma Fractionation Average Sales Price by Manufacturers (2019-2024)
3.4 Global Plasma Fractionation Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Plasma Fractionation Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Plasma Fractionation Manufacturers, Product Type & Application
3.7 Global Plasma Fractionation Manufacturers Commercialization Time
3.8 Market Competitive Analysis
  3.8.1 Global Plasma Fractionation Market CR5 and HHI
  3.8.2 Global Top 5 and 10 Plasma Fractionation Players Market Share by Revenue in 2023
  3.8.3 2023 Plasma Fractionation Tier 1, Tier 2, and Tier

4 PLASMA FRACTIONATION MARKET BY TYPE

4.1 Plasma Fractionation Type Introduction
  4.1.1 Albumin
  4.1.2 Immune Globulin
  4.1.3 Coagulation Factor
  4.1.4 Others
4.2 Global Plasma Fractionation Sales by Type
  4.2.1 Global Plasma Fractionation Sales by Type (2019 VS 2023 VS 2030)
  4.2.2 Global Plasma Fractionation Sales by Type (2019-2030)
  4.2.3 Global Plasma Fractionation Sales Market Share by Type (2019-2030)
4.3 Global Plasma Fractionation Revenue by Type
  4.3.1 Global Plasma Fractionation Revenue by Type (2019 VS 2023 VS 2030)
  4.3.2 Global Plasma Fractionation Revenue by Type (2019-2030)
  4.3.3 Global Plasma Fractionation Revenue Market Share by Type (2019-2030)

5 PLASMA FRACTIONATION MARKET BY APPLICATION

5.1 Plasma Fractionation Application Introduction
  5.1.1 Immunology
  5.1.2 Hematology
  5.1.3 Others
5.2 Global Plasma Fractionation Sales by Application
  5.2.1 Global Plasma Fractionation Sales by Application (2019 VS 2023 VS 2030)
  5.2.2 Global Plasma Fractionation Sales by Application (2019-2030)
  5.2.3 Global Plasma Fractionation Sales Market Share by Application (2019-2030)
5.3 Global Plasma Fractionation Revenue by Application
  5.3.1 Global Plasma Fractionation Revenue by Application (2019 VS 2023 VS 2030)
  5.3.2 Global Plasma Fractionation Revenue by Application (2019-2030)
  5.3.3 Global Plasma Fractionation Revenue Market Share by Application (2019-2030)

6 GLOBAL PLASMA FRACTIONATION SALES BY REGION

6.1 Global Plasma Fractionation Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Plasma Fractionation Sales by Region (2019-2030)
  6.2.1 Global Plasma Fractionation Sales by Region (2019-2024)
  6.2.2 Global Plasma Fractionation Sales Forecasted by Region (2025-2030)
6.3 North America
  6.3.1 North America Plasma Fractionation Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.3.2 North America Plasma Fractionation Sales by Country (2019-2030)
  6.3.3 U.S.
  6.3.4 Canada
6.4 Europe
  6.4.1 Europe Plasma Fractionation Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.4.2 Europe Plasma Fractionation Sales by Country (2019-2030)
  6.4.3 Germany
  6.4.4 France
  6.4.5 U.K.
  6.4.6 Italy
  6.4.7 Netherlands
6.5 Asia Pacific
  6.5.1 Asia Pacific Plasma Fractionation Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.5.2 Asia Pacific Plasma Fractionation Sales by Country (2019-2030)
  6.5.3 China
  6.5.4 Japan
  6.5.5 South Korea
  6.5.6 Southeast Asia
  6.5.7 India
  6.5.8 Australia
6.6 LAMEA
  6.6.1 LAMEA Plasma Fractionation Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.6.2 LAMEA Plasma Fractionation Sales by Country (2019-2030)
  6.6.3 Mexico
  6.6.4 Brazil
  6.6.5 Turkey
  6.6.6 GCC Countries

7 GLOBAL PLASMA FRACTIONATION REVENUE BY REGION

7.1 Global Plasma Fractionation Revenue by Region
  7.1.1 Global Plasma Fractionation Revenue by Region: 2019 VS 2023 VS 2030
  7.1.2 Global Plasma Fractionation Revenue by Region (2019-2024)
  7.1.3 Global Plasma Fractionation Revenue by Region (2025-2030)
  7.1.4 Global Plasma Fractionation Revenue Market Share by Region (2019-2030)
7.2 North America
  7.2.1 North America Plasma Fractionation Revenue (2019-2030)
  7.2.2 North America Plasma Fractionation Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
  7.3.1 Europe Plasma Fractionation Revenue (2019-2030)
  7.3.2 Europe Plasma Fractionation Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
  7.4.1 Asia-Pacific Plasma Fractionation Revenue (2019-2030)
  7.4.2 Asia-Pacific Plasma Fractionation Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
  7.5.1 LAMEA Plasma Fractionation Revenue (2019-2030)
  7.5.2 LAMEA Plasma Fractionation Revenue Share by Country: 2019 VS 2023 VS 2030

8 COMPANY PROFILES

8.1 Takeda
  8.1.1 Takeda Comapny Information
  8.1.2 Takeda Business Overview
  8.1.3 Takeda Plasma Fractionation Sales, Price, Revenue and Gross Margin (2019-2024)
  8.1.4 Takeda Plasma Fractionation Product Portfolio
  8.1.5 Takeda Recent Developments
8.2 CSL
  8.2.1 CSL Comapny Information
  8.2.2 CSL Business Overview
  8.2.3 CSL Plasma Fractionation Sales, Price, Revenue and Gross Margin (2019-2024)
  8.2.4 CSL Plasma Fractionation Product Portfolio
  8.2.5 CSL Recent Developments
8.3 Grifols
  8.3.1 Grifols Comapny Information
  8.3.2 Grifols Business Overview
  8.3.3 Grifols Plasma Fractionation Sales, Price, Revenue and Gross Margin (2019-2024)
  8.3.4 Grifols Plasma Fractionation Product Portfolio
  8.3.5 Grifols Recent Developments
8.4 Octapharma
  8.4.1 Octapharma Comapny Information
  8.4.2 Octapharma Business Overview
  8.4.3 Octapharma Plasma Fractionation Sales, Price, Revenue and Gross Margin (2019-2024)
  8.4.4 Octapharma Plasma Fractionation Product Portfolio
  8.4.5 Octapharma Recent Developments
8.5 Kedrion
  8.5.1 Kedrion Comapny Information
  8.5.2 Kedrion Business Overview
  8.5.3 Kedrion Plasma Fractionation Sales, Price, Revenue and Gross Margin (2019-2024)
  8.5.4 Kedrion Plasma Fractionation Product Portfolio
  8.5.5 Kedrion Recent Developments
8.6 LFB Group
  8.6.1 LFB Group Comapny Information
  8.6.2 LFB Group Business Overview
  8.6.3 LFB Group Plasma Fractionation Sales, Price, Revenue and Gross Margin (2019-2024)
  8.6.4 LFB Group Plasma Fractionation Product Portfolio
  8.6.5 LFB Group Recent Developments
8.7 Biotest
  8.7.1 Biotest Comapny Information
  8.7.2 Biotest Business Overview
  8.7.3 Biotest Plasma Fractionation Sales, Price, Revenue and Gross Margin (2019-2024)
  8.7.4 Biotest Plasma Fractionation Product Portfolio
  8.7.5 Biotest Recent Developments
8.8 BPL
  8.8.1 BPL Comapny Information
  8.8.2 BPL Business Overview
  8.8.3 BPL Plasma Fractionation Sales, Price, Revenue and Gross Margin (2019-2024)
  8.8.4 BPL Plasma Fractionation Product Portfolio
  8.8.5 BPL Recent Developments
8.9 RAAS
  8.9.1 RAAS Comapny Information
  8.9.2 RAAS Business Overview
  8.9.3 RAAS Plasma Fractionation Sales, Price, Revenue and Gross Margin (2019-2024)
  8.9.4 RAAS Plasma Fractionation Product Portfolio
  8.9.5 RAAS Recent Developments
8.10 CBPO
  8.10.1 CBPO Comapny Information
  8.10.2 CBPO Business Overview
  8.10.3 CBPO Plasma Fractionation Sales, Price, Revenue and Gross Margin (2019-2024)
  8.10.4 CBPO Plasma Fractionation Product Portfolio
  8.10.5 CBPO Recent Developments
8.11 Hualan Bio
  8.11.1 Hualan Bio Comapny Information
  8.11.2 Hualan Bio Business Overview
  8.11.3 Hualan Bio Plasma Fractionation Sales, Price, Revenue and Gross Margin (2019-2024)
  8.11.4 Hualan Bio Plasma Fractionation Product Portfolio
  8.11.5 Hualan Bio Recent Developments

9 VALUE CHAIN AND SALES CHANNELS ANALYSIS

9.1 Plasma Fractionation Value Chain Analysis
  9.1.1 Plasma Fractionation Key Raw Materials
  9.1.2 Raw Materials Key Suppliers
  9.1.3 Manufacturing Cost Structure
  9.1.4 Plasma Fractionation Production Mode & Process
9.2 Plasma Fractionation Sales Channels Analysis
  9.2.1 Direct Comparison with Distribution Share
  9.2.2 Plasma Fractionation Distributors
  9.2.3 Plasma Fractionation Customers

10 CONCLUDING INSIGHTS

11 APPENDIX

11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
  11.5.1 Secondary Sources
  11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES

Table 1. Plasma Fractionation Industry Trends
Table 2. Plasma Fractionation Industry Drivers
Table 3. Plasma Fractionation Industry Opportunities and Challenges
Table 4. Plasma Fractionation Industry Restraints
Table 5. Global Plasma Fractionation Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Plasma Fractionation Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Plasma Fractionation Sales by Manufacturers (K Units) & (2019-2024)
Table 8. Global Plasma Fractionation Sales Market Share by Manufacturers
Table 9. Global Plasma Fractionation Average Sales Price (US$/Unit) of Manufacturers (2019-2024)
Table 10. Global Plasma Fractionation Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Plasma Fractionation Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Plasma Fractionation Manufacturers, Product Type & Application
Table 13. Global Plasma Fractionation Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Plasma Fractionation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Albumin
Table 17. Major Manufacturers of Immune Globulin
Table 18. Major Manufacturers of Coagulation Factor
Table 19. Major Manufacturers of Others
Table 20. Global Plasma Fractionation Sales by Type 2019 VS 2023 VS 2030 (K Units)
Table 21. Global Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 22. Global Plasma Fractionation Sales by Type (2025-2030) & (K Units)
Table 23. Global Plasma Fractionation Sales Market Share by Type (2019-2024)
Table 24. Global Plasma Fractionation Sales Market Share by Type (2025-2030)
Table 25. Global Plasma Fractionation Revenue by Type 2019 VS 2023 VS 2030 (K Units)
Table 26. Global Plasma Fractionation Revenue by Type (2019-2024) & (K Units)
Table 27. Global Plasma Fractionation Revenue by Type (2025-2030) & (K Units)
Table 28. Global Plasma Fractionation Revenue Market Share by Type (2019-2024)
Table 29. Global Plasma Fractionation Revenue Market Share by Type (2025-2030)
Table 30. Major Manufacturers of Immunology
Table 31. Major Manufacturers of Hematology
Table 32. Major Manufacturers of Others
Table 33. Global Plasma Fractionation Sales by Application 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 35. Global Plasma Fractionation Sales by Application (2025-2030) & (K Units)
Table 36. Global Plasma Fractionation Sales Market Share by Application (2019-2024)
Table 37. Global Plasma Fractionation Sales Market Share by Application (2025-2030)
Table 38. Global Plasma Fractionation Revenue by Application 2019 VS 2023 VS 2030 (K Units)
Table 39. Global Plasma Fractionation Revenue by Application (2019-2024) & (K Units)
Table 40. Global Plasma Fractionation Revenue by Application (2025-2030) & (K Units)
Table 41. Global Plasma Fractionation Revenue Market Share by Application (2019-2024)
Table 42. Global Plasma Fractionation Revenue Market Share by Application (2025-2030)
Table 43. Global Plasma Fractionation Sales by Region: 2019 VS 2023 VS 2030 (K Units)
Table 44. Global Plasma Fractionation Sales by Region (2019-2024) & (K Units)
Table 45. Global Plasma Fractionation Sales Market Share by Region (2019-2024)
Table 46. Global Plasma Fractionation Sales Forecasted by Region (2025-2030) & (K Units)
Table 47. Global Plasma Fractionation Sales Forecasted Market Share by Region (2025-2030)
Table 48. North America Plasma Fractionation Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 49. North America Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 50. North America Plasma Fractionation Sales by Country (2025-2030) & (K Units)
Table 51. Europe Plasma Fractionation Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 52. Europe Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 53. Europe Plasma Fractionation Sales by Country (2025-2030) & (K Units)
Table 54. Asia Pacific Plasma Fractionation Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 55. Asia Pacific Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 56. Asia Pacific Plasma Fractionation Sales by Country (2025-2030) & (K Units)
Table 57. LAMEA Plasma Fractionation Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 58. LAMEA Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 59. LAMEA Plasma Fractionation Sales by Country (2025-2030) & (K Units)
Table 60. Global Plasma Fractionation Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 61. Global Plasma Fractionation Revenue by Region (2019-2024) & (US$ Million)
Table 62. Global Plasma Fractionation Revenue by Region (2025-2030) & (US$ Million)
Table 63. Global Plasma Fractionation Revenue Market Share by Region (2019-2024)
Table 64. Global Plasma Fractionation Revenue Market Share by Region (2025-2030)
Table 65. Takeda Company Information
Table 66. Takeda Business Overview
Table 67. Takeda Plasma Fractionation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 68. Takeda Plasma Fractionation Product Portfolio
Table 69. Takeda Recent Development
Table 70. CSL Company Information
Table 71. CSL Business Overview
Table 72. CSL Plasma Fractionation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 73. CSL Plasma Fractionation Product Portfolio
Table 74. CSL Recent Development
Table 75. Grifols Company Information
Table 76. Grifols Business Overview
Table 77. Grifols Plasma Fractionation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. Grifols Plasma Fractionation Product Portfolio
Table 79. Grifols Recent Development
Table 80. Octapharma Company Information
Table 81. Octapharma Business Overview
Table 82. Octapharma Plasma Fractionation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 83. Octapharma Plasma Fractionation Product Portfolio
Table 84. Octapharma Recent Development
Table 85. Kedrion Company Information
Table 86. Kedrion Business Overview
Table 87. Kedrion Plasma Fractionation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 88. Kedrion Plasma Fractionation Product Portfolio
Table 89. Kedrion Recent Development
Table 90. LFB Group Company Information
Table 91. LFB Group Business Overview
Table 92. LFB Group Plasma Fractionation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 93. LFB Group Plasma Fractionation Product Portfolio
Table 94. LFB Group Recent Development
Table 95. Biotest Company Information
Table 96. Biotest Business Overview
Table 97. Biotest Plasma Fractionation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 98. Biotest Plasma Fractionation Product Portfolio
Table 99. Biotest Recent Development
Table 100. BPL Company Information
Table 101. BPL Business Overview
Table 102. BPL Plasma Fractionation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 103. BPL Plasma Fractionation Product Portfolio
Table 104. BPL Recent Development
Table 105. RAAS Company Information
Table 106. RAAS Business Overview
Table 107. RAAS Plasma Fractionation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 108. RAAS Plasma Fractionation Product Portfolio
Table 109. RAAS Recent Development
Table 110. CBPO Company Information
Table 111. CBPO Business Overview
Table 112. CBPO Plasma Fractionation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 113. CBPO Plasma Fractionation Product Portfolio
Table 114. CBPO Recent Development
Table 115. Hualan Bio Company Information
Table 116. Hualan Bio Business Overview
Table 117. Hualan Bio Plasma Fractionation Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 118. Hualan Bio Plasma Fractionation Product Portfolio
Table 119. Hualan Bio Recent Development
Table 120. Key Raw Materials
Table 121. Raw Materials Key Suppliers
Table 122. Plasma Fractionation Distributors List
Table 123. Plasma Fractionation Customers List
Table 124. Research Programs/Design for This Report
Table 125. Authors List of This Report
Table 126. Secondary Sources
Table 127. Primary Sources

LIST OF FIGURES

Figure 1. Plasma Fractionation Product Picture
Figure 2. Global Plasma Fractionation Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Plasma Fractionation Market Size (2019-2030) & (US$ Million)
Figure 4. Global Plasma Fractionation Sales (2019-2030) & (K Units)
Figure 5. Global Plasma Fractionation Average Price (US$/Unit) & (2019-2030)
Figure 6. Global Top 5 and 10 Plasma Fractionation Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Albumin Picture
Figure 9. Immune Globulin Picture
Figure 10. Coagulation Factor Picture
Figure 11. Others Picture
Figure 12. Global Plasma Fractionation Sales by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 13. Global Plasma Fractionation Sales Market Share 2019 VS 2023 VS 2030
Figure 14. Global Plasma Fractionation Sales Market Share by Type (2019-2030)
Figure 15. Global Plasma Fractionation Revenue by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Plasma Fractionation Revenue Market Share 2019 VS 2023 VS 2030
Figure 17. Global Plasma Fractionation Revenue Market Share by Type (2019-2030)
Figure 18. Immunology Picture
Figure 19. Hematology Picture
Figure 20. Others Picture
Figure 21. Global Plasma Fractionation Sales by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 22. Global Plasma Fractionation Sales Market Share 2019 VS 2023 VS 2030
Figure 23. Global Plasma Fractionation Sales Market Share by Application (2019-2030)
Figure 24. Global Plasma Fractionation Revenue by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Plasma Fractionation Revenue Market Share 2019 VS 2023 VS 2030
Figure 26. Global Plasma Fractionation Revenue Market Share by Application (2019-2030)
Figure 27. North America Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 28. North America Plasma Fractionation Sales Market Share by Country (2019-2030)
Figure 29. U.S. Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 30. Canada Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 31. Europe Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 32. Europe Plasma Fractionation Sales Market Share by Country (2019-2030)
Figure 33. Germany Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 34. France Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 35. U.K. Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 36. Italy Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 37. Netherlands Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 38. Asia Pacific Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 39. Asia Pacific Plasma Fractionation Sales Market Share by Country (2019-2030)
Figure 40. China Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 41. Japan Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 42. South Korea Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 43. Southeast Asia Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 44. India Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 45. Australia Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 46. LAMEA Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 47. LAMEA Plasma Fractionation Sales Market Share by Country (2019-2030)
Figure 48. Mexico Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 49. Brazil Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 50. Turkey Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 51. GCC Countries Plasma Fractionation Sales and Growth Rate (2019-2030) & (K Units)
Figure 52. Global Plasma Fractionation Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 53. Global Plasma Fractionation Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 54. North America Plasma Fractionation Revenue (2019-2030) & (US$ Million)
Figure 55. North America Plasma Fractionation Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Europe Plasma Fractionation Revenue (2019-2030) & (US$ Million)
Figure 57. Europe Plasma Fractionation Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. Asia-Pacific Plasma Fractionation Revenue (2019-2030) & (US$ Million)
Figure 59. Asia-Pacific Plasma Fractionation Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. LAMEA Plasma Fractionation Revenue (2019-2030) & (US$ Million)
Figure 61. LAMEA Plasma Fractionation Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 62. Plasma Fractionation Value Chain
Figure 63. Manufacturing Cost Structure
Figure 64. Plasma Fractionation Production Mode & Process
Figure 65. Direct Comparison with Distribution Share
Figure 66. Distributors Profiles
Figure 67. Years Considered
Figure 68. Research Process
Figure 69. Key Executives Interviewed


More Publications